Gene clues could unlock better Crohn's treatment
NCT ID NCT07263464
First seen Jan 05, 2026 · Last updated May 18, 2026 · Updated 22 times
Summary
This study looked at whether differences in a gene called TNFSF4 affect a person's chance of developing Crohn's disease and how well they respond to the drug ustekinumab. Researchers analyzed blood samples from 818 people with Crohn's disease. The goal was to find genetic markers that could help personalize treatment in the future.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLAMMATORY BOWEL DISEASE (CROHN'S DISEASE AND ULCERATIVE COLITIS) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
the Second Affiliated Hospital of Wenzhou Medical University
Wenzhou, Zhejiang, China
Conditions
Explore the condition pages connected to this study.